Regulation of the function of EGF receptors via P_2 purinergic receptors and related cell signaling systems

通过P_2嘌呤能受体和相关细胞信号系统调节EGF受体的功能

基本信息

项目摘要

We studied how stimulation of the purinergic receptors and other receptors (bradykinin receptors) elicites the cell signalling and affects other rceptors, e.g.the EGF receptor. We used A-431 human epidermoid carcinoma cells for the present experiment since they express high level of EGF receptors in addition to P_2 purinergic receptors. The stimulation of P_2 purinergic receptors stimulated PLC activity, followed by the PKC activation and [Ca^<2+>]_i elevation. From the ligand specificity to increase [Ca^<2+>]_i, the purinergic receptors responsible for provoking such cellular activity are suggested to be the P_<2Y> or P_<2U>-type. All the nucleotides that increased [Ca^<2+>]_i also inhibited the EGF receptor high affinity bindnig indicating that the function of EGF receptors is regulated by P_2 purinergic receptors via the cellular signal transduction system. The EGF high affinity binding was also inhibited when the cells were stimulated by bradykinin. However, the inhibition by bradykinin of the EGF high affinity binding was transient. Bradykinin was shown to stimulate a phosphoprotein phosphatase (s) as well as protein kinase C.Such biphasic effects of bradykinin to phosphorylate and dephosphorylate EGF receptors imply a homeostatic control of the receptor function in regulating phopshorylation level. In addition to PLC activation, stimulation by EGF and ATP activated either DG kinase or PLD which in turn supplied PA and activated PKC/ [Ca2+]i system, all of which were found to be essential for the stimulation of PI synthesis. The present results imply the general prospect that ligand stimulation, which mobilizes second messengers and consumes their precursors, simultaneously provokes the pathway to synthesize and salvage the second messenger precursors.
我们研究了嘌呤能受体和其他受体(缓激肽受体)的刺激如何引发细胞信号传导并影响其他受体,例如EGF受体。由于A-431人表皮样癌细胞除P_2嘌呤能受体外,还表达高水平的EGF受体,故本实验选用A-431人表皮样癌细胞。P_2嘌呤能受体激活PLC活性,PKC激活,[Ca^<2+>] i升高。从配体特异性增加[Ca^&lt;2+&gt;]_i的角度,推测引起这种细胞活性的嘌呤能受体为P_<2Y>或P_<2U>-型。所有增加[Ca^&lt;2+&gt;]_i的核苷酸均抑制EGF受体的高亲和力结合,表明EGF受体的功能受P_2嘌呤受体通过细胞信号转导系统的调节。缓激肽刺激细胞后,EGF高亲和力结合也受到抑制。然而,缓激肽对EGF高亲和力结合的抑制是短暂的。缓激肽被证明刺激磷蛋白磷酸酶以及蛋白激酶C。缓激肽磷酸化和去磷酸化EGF受体的这种双相作用意味着在调节磷酸化水平中对受体功能的稳态控制。除PLC激活外,EGF和ATP刺激还激活DG激酶或PLD,进而提供PA和激活PKC/ [Ca ~(2+)]i系统,所有这些都被发现是刺激PI合成所必需的。目前的研究结果暗示了一般的前景,配体刺激,动员第二信使和消耗其前体,同时激发的途径,合成和抢救的第二信使前体。

项目成果

期刊论文数量(132)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hosoi, K., Tsunasawa, S., Aoyama, H., Kurihara, K., Ueha, T., Murai, T.and Sakiyama, F.: "Identification of mKl.a true tissue (glandular) kallikrein of mouse subman dibular gland : Tissue distribution and a comparison of kinin-releasing activity with othe
Hosoi, K.、Tsunasawa, S.、Aoyama, H.、Kurihara, K.、Ueha, T.、Murai, T. 和 Sakiyama, F.:“小鼠亚人 mKl.a 真实组织(腺体)激肽释放酶的鉴定
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hosoi, K.: "Effect of mastication on bioactive factors in the salivary gland (in Japanses)" Journal of Mastication & Health Society. 3(1). 11-16 (1993)
Hosoi, K.:“咀嚼对唾液腺生物活性因子的影响(日本)”咀嚼杂志
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Isomata, K., Ueha, T., Kurahashi, S., Sugaya, E., Furuyama, S., Hosoi, K., and Murakami, T.: Standear Oral Physiology (ed.by Ueha, T., in Japanese). Gakken-Shoin, 366 (1994)
Isomata, K.、Ueha, T.、Kurahashi, S.、Sugaya, E.、Furuyama, S.、Hosoi, K. 和 Murakami, T.:Standear Oral Physiology(由 Ueha, T. 编辑,日文版)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hosoi, K., et al.: Experimental Manual for Molecular Cell Biology (ed.by Kakuno, T., Horiuti, Y., Nishikawa, K., Matsuo, Y., Higuti, T., and Miyazaki, K., in Japanses). Nanko-Do, 506 (1994)
Hosoi, K., et al.:分子细胞生物学实验手册(作者:Kakuno, T.、Horiuti, Y.、Nishikawa, K.、Matsuo, Y.、Higuti, T. 和 Miyazaki, K.,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hosoi,K.et al.: "Additive and/or synergistic of 5α-dihydrotestosterone,dexamethasone,and triiodo-L-thyronine on..." Endocrinology. 130(2). 1044-1055 (1992)
Hosoi, K. 等人:“5α-二氢睾酮、地塞米松和三碘-L-甲状腺氨酸的添加剂和/或协同作用......”内分泌学 130(2) (1992)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HOSOI Kazuo其他文献

HOSOI Kazuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HOSOI Kazuo', 18)}}的其他基金

Moecular meohanism of expression and regulation of the water channe1, aquapor in 5 in the exocrine gland
外分泌腺水通道1、水通道5表达与调节的分子机制
  • 批准号:
    18390493
  • 财政年份:
    2006
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of expression and regulation of water channel proteins aquaporins in the exocrine gland cells
外分泌腺细胞水通道蛋白水通道蛋白表达与调控的分子机制
  • 批准号:
    13671940
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inflammation by mast cell kininogen and its suppression -Development of a new drug
肥大细胞激肽原引起的炎症及其抑制-新药的开发
  • 批准号:
    13557154
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A new physiologic function of tissue kallikrein family enzymes and processing of growth factor precursors
组织激肽释放酶家族酶的新生理功能和生长因子前体的加工
  • 批准号:
    08672129
  • 财政年份:
    1996
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of extracellular ATP on Ca^<2+> movement, and phosphoinositide metabolism, leading to a functional change of EGF receptor
细胞外ATP对Ca^2运动和磷酸肌醇代谢的影响,导致EGF受体功能改变
  • 批准号:
    62570840
  • 财政年份:
    1987
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer
乳腺癌中的 c-Src/EGF 受体相互作用和治疗耐药
  • 批准号:
    7254940
  • 财政年份:
    2006
  • 资助金额:
    $ 1.15万
  • 项目类别:
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer
乳腺癌中的 c-Src/EGF 受体相互作用和治疗耐药
  • 批准号:
    7629190
  • 财政年份:
    2006
  • 资助金额:
    $ 1.15万
  • 项目类别:
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer
乳腺癌中的 c-Src/EGF 受体相互作用和治疗耐药
  • 批准号:
    7428876
  • 财政年份:
    2006
  • 资助金额:
    $ 1.15万
  • 项目类别:
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer
乳腺癌中的 c-Src/EGF 受体相互作用和治疗耐药
  • 批准号:
    7826710
  • 财政年份:
    2006
  • 资助金额:
    $ 1.15万
  • 项目类别:
c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer
乳腺癌中的 c-Src/EGF 受体相互作用和治疗耐药
  • 批准号:
    7135324
  • 财政年份:
    2006
  • 资助金额:
    $ 1.15万
  • 项目类别:
Regulation of EGF Receptors by G protein receptor
G蛋白受体对EGF受体的调节
  • 批准号:
    6368869
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
Regulation of EGF Receptors by G protein receptor
G蛋白受体对EGF受体的调节
  • 批准号:
    6526032
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
Regulation of EGF Receptors by G protein receptor
G蛋白受体对EGF受体的调节
  • 批准号:
    6785962
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
Regulation of EGF Receptors by G protein receptor
G蛋白受体对EGF受体的调节
  • 批准号:
    6642044
  • 财政年份:
    2001
  • 资助金额:
    $ 1.15万
  • 项目类别:
REGULATION OF EGF RECEPTORS BY CALCIOTROPIC HORMONES
促钙激素对 EGF 受体的调节
  • 批准号:
    6177512
  • 财政年份:
    1996
  • 资助金额:
    $ 1.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了